Early Monitoring of Response (MORE) to Golimumab Therapy Based on Fecal Calprotectin and Trough Serum Levels in Patients With Ulcerative Colitis: A Multicenter Prospective Study

Attyla Drabik   ¹ , MD ;   Andreas Sturm   ² , PhD, MD ;   Margit Blömacher   ³ , PhD ;   Ulf Helwig   ⁴ , PhD, MD

¹ Clinical Trial Support, Münster, Germany

² DRK Kliniken Berlin Westend, Department of Gastroenterology, Berlin, Germany

³ Kompetenznetz Darmerkrankungen e. V., Kiel, Germany

⁴ Medical Practice for Internal Medicine Oldenburg, Oldenburg, Germany